Cor Vasa 2010, 52(4):244-251 | DOI: 10.33678/cor.2010.060

Percutaneous renal artery angioplasty: indications, surgical technique, and long-term outcomes

Michael Želízko1,*, Marcela Bürgelová2, Vladimír Pořízka1, Vladimír Karmazín1, Vladimír Teplan2
1 Klinika kardiologie, Institut klinické a experimentální medicíny
2 Klinika nefrologie, Institut klinické a experimentální medicíny, Praha, Česká republika

Aim: The purpose of the study was 1) to investigate the incidence of significant renal artery stenosis in patients undergoing coronary angiography, 2) to assess the significance of renal artery stenosis by angiography and intravascular ultrasound (IVUS), 3) to evaluate the plaque composition by virtual histology (VH) and 4) to analyze predictors of renal angioplasty success or failure.

Methods: Patients with significant renal artery stenosis by angiography (stenosis diameter ≥ 70%) underwent intravascular ultrasound assessment and plaque characterization by virtual histology. Renal blood flow was assessed by renal frame count and renal blush grade. Renal angioplasty and stenting (PTRA) was performed using the coronary technique with direct stenting. All patients were on follow-up by a nephrologist for one year.

Results: The incidence of significant renal artery stenosis was 0.9% in the population of cardiology patients. Thirty five consecutive patients at high cardiovascular risk (18 males, 17 females, age 68 ± 7.9 years) and 41 renal artery stenoses underwent renal artery stenting. The stenosis diameter was 61.2 ± 9.3% by quantitative angiography (QCA) and 63.9 ± 7.8% by IVUS and the area of stenosis was 78.5 ± 9.8% by QCA and 79.3 ± 9.1% by IVUS (r = 0.43, p < 0.01). The plaque composition by VH was fibrous (57.7 ± 11.3%), fibro-fatty (27.8 ± 15.3%), deep calcium (4.5 ± 5.8%) and diffuse necrotic (10.1 ± 7.6%) but without presence of thin intimal cap fibroatheroma. The technical success rate of PTRA was 100% without any major adverse cardiovascular events or reinterventions during hospitalization. At follow-up (12.9 ± 4.6 months), there was a significant decrease in systolic blood pressure (BP) from 166.4 ± 21.0 mmHg to 148.5 ± 23.8 mmHg (p = 0.01) and diastolic BP from 83.5 ± 11.4 mmHg to 78.6 ± 7.6 mmHg (p = 0,05). Creatinine decreased from 132.7 ± 52.11 µmol/l to 130.6 ± 74.3 µmol/l (p = 0.05). Clinical success of PTRA was achieved in 28 out of 35 patients (80%), while in 7 patients (20%) there was no response. Neither baseline demographic factors nor current symptoms, renal flow, stenosis severity or creatinine were predictors of PTRA success or failure.

Conclusions: The incidence of significant renal artery stenosis is 1% in cardiology patients. The plaque is composed of fibrous tissue with a deep calcium and low vulnerability index. Renal artery stenosis assessment by angiography correlates with IVUS measurements. PTRA is a feasible and safe procedure with a technical success rate close to 100% and clinical success rate in 80% patients. There are no predictors of PTRA success or failure.

Keywords: Renal artery stenosis; Hypertension; Renal artery stenting; Intravascular ultrasound; Virtual histology

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Želízko M, Bürgelová M, Pořízka V, Karmazín V, Teplan V. Percutaneous renal artery angioplasty: indications, surgical technique, and long-term outcomes. Cor Vasa. 2010;52(4):244-251. doi: 10.33678/cor.2010.060.
Download citation

References

  1. El-Mawardy RH, Ghareeb MA, Mahdy MM, et al. Prevalence and predictors of renal artery stenosis in hypertensive patients undergoing elective coronary procedures. J Clinical Hypertens 2008;10:844-849. Go to original source... Go to PubMed...
  2. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342:1007-1014. Go to original source... Go to PubMed...
  3. ASTRAL Investigators, Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361: 1953-1962. Go to original source... Go to PubMed...
  4. Schwarzwälder U, Hauk M, Zeller T. RADAR - a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials 2009;10:60. Go to original source... Go to PubMed...
  5. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329-335. Go to original source... Go to PubMed...
  6. Rocha-Singh KJ, Ahuja RK, Sung CH, Rutherford J. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv 2002;57:135-141. Go to original source... Go to PubMed...
  7. Zeller T, Frank U, Müller C, et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther 2004;11:95-106. Go to original source... Go to PubMed...
  8. Scarpioni R, Michieletti E, Cristinelli L, et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). J Nephrol 2005;18:423-428. Go to PubMed...
  9. Coen G, Moscaritolo E, Catalano C, et al. Atherosclerotic renal artery stenosis: one-year outcome of total and separate kidney function following stenting. BMC Nephrol 2004;5:15. Go to original source... Go to PubMed...
  10. Rastan A, Krankenberg H, Müller-Hülsbeck S, et al. Improved renal function and blood pressure control following renal artery angioplasty: the renal artery angioplasty in patients with renal insufficiency and hypertension using a dedicated renal stent device study (PRECISION). EuroIntervention 2008;4:208-213. Go to original source... Go to PubMed...
  11. Beutler J, Van Ampting JM, Van De Ven PJ, et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001;12:1475-1481. Go to original source... Go to PubMed...
  12. Tan J, Filobbos R, Raghunathan G, et al. Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney. Nephrol Dial Transplant 2007;22:1916-1919. Go to original source... Go to PubMed...
  13. Gray BH, Olin JW, Childs MB, et al. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med 2002;7:275-279. Go to original source... Go to PubMed...
  14. Marcantoni C, Zanoli L, Rastelli S, et al. Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial. J Nephrol 2009;22:13-16. Go to PubMed...
  15. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 2006;113: e463-e465. Go to original source... Go to PubMed...
  16. König A, Klauss V. Virtual histology. Heart 2007;93:977-982. Go to original source... Go to PubMed...
  17. Diethrich EB, Irshad K, Reid DB. Virtual histology and color flow intravascular ultrasound in peripheral interventions. Semin Vasc Surg 2006;19: 155-162. Go to original source... Go to PubMed...
  18. Mahmud E, Smith TWR, Palakodeti V, et al. Renal frame count and renal blush grade. Quantitative measures that predict the success of renal stenting in hypertensive patients with renal artery stenosis. J Am Coll Cardiol: Cardiovasc Interv 2008;1:286-292. Go to original source... Go to PubMed...
  19. Tsao CR, Lee WL, Liu TJ, et al. Delicate percutaneous renal artery stenting minimizes postoperative renal injury and protects kidney in patients with severe atherosclerotic renal artery stenosis and impaired renal function. Int Heart J 2005;46:1061-1072. Go to original source... Go to PubMed...
  20. Subramanian R, White CHJ, Rosenfield K, et al. Renal fractional flow reserve. A hemodynamic evaluation of moderate renal artery stenoses. Cathether Cardiovasc Interv 2005;64:480-486. Go to original source... Go to PubMed...
  21. De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 2006;48:1851-1855. Go to original source... Go to PubMed...
  22. Dangas G, Laird JR, Mehran R, et al. Intravascular ultrasound-guided renal artery stenting. J Endovasc Ther 2001;8:238-247. Go to original source...
  23. Okubo M, Kawasaki M, Ishihara Y, et al. Tissue characterization of coronary plaques: comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasound. Circ J 2008;72: 1631-1639. Go to original source... Go to PubMed...
  24. Missel E, Mintz GS, Carlier SG, et al. Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. Am J Cardiol 2008;101:573-578. Go to original source... Go to PubMed...
  25. Bittl JA. Damage control for renal artery stenting. Circulation 2008;117: 2724-2726. Go to original source... Go to PubMed...
  26. Cooper CJ, Haller ST, Colyer W, et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation 2008;117:2752-2760. Go to original source... Go to PubMed...
  27. Klonaris C, Katsargyris A, Alexandrou A, et al. Efficacy of protected renal artery primary stenting in the solitary functioning kidney. J Vasc Surg 2008; 48:1414-1422. Go to original source... Go to PubMed...
  28. Zeller T, Rastan A, Rothenpieler U, Müller C. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents? Catheter Cardiovasc Interv 2006;68:125-130. Go to original source... Go to PubMed...
  29. Zähringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther 2007;14:460-468. Go to original source... Go to PubMed...
  30. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J 2000;139 (1 Pt 1):64-71. Go to original source... Go to PubMed...
  31. Zeller T, Frank U, Müller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003;108:2244-2249. Go to original source... Go to PubMed...
  32. Textor SC. Atherosclerotic renal artery stenosis: overtreated but underrated? J Am Soc Nephrol 2008;19:656-659. Go to original source... Go to PubMed...
  33. Safian RD, Madder RD. Refining the approach to renal artery revascularization. J Am Coll Cardiol: Cardiovasc Interv 2009;2:161-174. Go to original source... Go to PubMed...
  34. Textor SC, McKusick MM, Misra S, Glockner J. Timing and selection for renal revascularization in an era of negative trials: what to do? Prog Cardiovasc Dis 2009;52:220-228. Go to original source... Go to PubMed...
  35. Textor SC, Lerman L, McKusick M. The uncertain value of renal artery interventions: where are we now? J Am Coll Cardiol: Cardiovasc Interv 2009;2:175-182. Go to original source... Go to PubMed...
  36. Schwarzwälder U, Zeller T. Critical review of indications for renal artery stenting: do randomized trials give the answer? Catheter Cardiovasc Interv 2009;74:251-256. Go to original source... Go to PubMed...
  37. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006;152:59-66. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.